Antisense Oligonucleotide Clinical Guidance Emphasizes Individualized Nature Of Treatment

 
• By Sue Sutter
Flowers in field
In FDA's view, a study for an individualized ASO therapy will involve 1 or 2 patients. • Source: Alamy

More from Rare Diseases

More from Pink Sheet